Cynata Therapeutics LimitedASX: CYP

Paul Wotton to Resign as Director from AGM

· Issued by Cynata Therapeutics Limited via ASX

Filed with ASX · · 1 page · English

Summary by 6ix AI

Cynata Therapeutics Limited announces the resignation of Dr Paul Wotton as a Director, effective after the upcoming Annual General Meeting. The Chair of the Board, Dr Geoff Brooke, expressed gratitude for Dr Wotton's significant contributions during his tenure. Dr Wotton stated that it was a privilege to serve and that now is the right time for him to step down due to increasing commitments.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/paul-wotton-to-resign-as-director-from-agm

Release

ASX ANNOUNCEMENT 22 October 2026 Director Resignation Melbourne, Australia; 22 October 2026: Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), advises that Dr Paul Wotton will resign as a Director, effective from the conclusion of the Company’s Annual General...

Cynata Therapeutics Limited on 6ix

Story so far

Earlier from Cynata Therapeutics

Later from Cynata Therapeutics

All Cynata Therapeutics news releases